Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.
about
What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement.
P2860
Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@en
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@nl
type
label
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@en
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@nl
prefLabel
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@en
Cardiovascular risk assessment ...... entify monogenic dyslipidemia.
@nl
P2860
P50
P356
P1476
Cardiovascular risk assessment ...... dentify monogenic dyslipidemia
@en
P2093
Pediatric Investigators of the Portuguese Familial Hypercholesterolemia Study
P2860
P304
P356
10.1194/JLR.P043182
P577
2014-03-13T00:00:00Z